Two-Year Evaluation of Anti-retroviral Medicines Availability and Utilization in Supported Health Facilities in Osun State
Barre latérale de l'article
Contenu principal de l'article
Résumé
Background: Antiretroviral (ARV) drugs have reduced the burden of human immune-deficiency virus globally availability of these medicines and adherence to treatment guideline are crucial in sustaining the control of the infection. This study aims to evaluate the availability and use of ARV medicines in supported health facilities in Osun State over 2 years.
Methods: Combined Report and Requisition Forms of antiretroviral medicines prepared and transmitted, via e-mail to the State Logistics Management Coordinating Unit, between January 2017 and December 2018 from the HIV clinics of supported health facilities were reviewed. The collated data were analyzed using Microsoft Excel® software package.
Results: Patients that were on ARV medicines in the period was 3555.9 ± 1170.35 (100%). The patients were comprised of 3068.4 ± 846.02 (86.29%) and 107.7 ± 87.31 (3.03%) adults on first and second-line ARV medicines respectively. The paediatrics on first and second-line ARV medicines were 195.3±123.25 (5.49%) and 14.2±12.19 (0.40%) respectively. Tenofovir/lamivudine/efavirenz (TDF/3TC/EFV) was the most commonly ordered, supplied and consumed drug regimen, followed by Zidovudine/lamivudine/ nevirapine (AZT/3TC/NVP). The adult first line fixed dose combinations were mostly ordered, supplied and consumed (85.63%, 85.38%, 85.83%), followed by paediatric first line fixed combinations (7.84%, 8.04%, 8.09%) and then adult second-line components (2.72%, 2.81%, 2.65%). The overall performance was 101.1%.
Conclusion: ARV medicines used for patients in this study are in line with recommended standards. The first line ARV combination regimens (Tenofovir/lamivudine/efavirenz) were the most commonly ordered, supplied and consumed for both adults and paediatric populations.
Téléchargements
Renseignements sur l'article
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
Références
.UNAIDS. How AIDS changed everything – MDG6: 15 years, 15 lessons of hope from the AIDS response. Geneva: Joint United Nations Programme on HIV/AIDS; (2015)
http://www.unaids.org/sites/default/files/mediaasset/MD G6 Report_en .pdf, Accessed May 2023.
. World Health Organization. Global HIV/AIDS response. Available at: www.who.int/gho/data. A publication of the World Health Organization, Geneva (2010). Accessed May 2023
.World Health Organization. Scaling up HIV/AIDS care: service delivery and human resources perspectives. World Health Organization, Geneva. Available at: http://www.who.int/hrh/ documents/en/HRHAstRT_paper.pdf. (2004). A publication of the World Health Organization, Geneva. Accessed 30 May 2023
.Harries, A. D., Schouten, E. J., Makombe, S. D., Libamba, E., Neufville, H. N., Some, E.,
Kadewere, G. and Lungu, D. Ensuring uninterrupted supplies of antiretroviral Medicines in
resource-poor settings: an example from Malawi. Bulletin of the World Health Organization;
(2007). 85(2): 152 – 155.
.World Health Organization. Consolidated Guidelines on the use of antiretroviral Medicines for treating and preventing HIV infection. Recommendation for a public health approach. (2016) 2nd Edition. A publication of the World Health Organization, Geneva.
.Osun State Ministry of Health (SMoH). Osun State Quarterly Stock Status Report for Antiretroviral Medicines, Cotrimoxazole and HIV Rapid Test Kits, (2014), 1st Edition. Osun State Ministry of Health.
.Akanmu, S. A., Usman, S. O., Oreagba, I. A., Agbaje, O. E., Oshikoya, K., Ganiyu, A. A. and
Opanuga, O. O. Antiretroviral and co-prescribed Medicines for people living with HIV/AIDS
(PLWHA) in a university teaching hospital, south west Nigeria. West African Journal of
Pharmacists; (2015). 26 (2): 1-13.
.Ejikeme, N. and Godwin, A. P. Prevalence of Mycobacterium Tuberculosisi and Human
Immunodeficiency Virus (HIV) Infections in Umuahia, Abia State, Nigeria. African Journal of
Microbiology Research (2010).;4(14): 1486-1490.
.Olaniran, O., Hassan-Olajokun, R. E., Oyovwevotu, M. A. and Agunlejika, R. A. Prevalence of Tuberculosis among HIV/AIDS Patients in Obafemi Awolowo University Teaching Hospital
Complex OAUTHC, ILE-IFE. International Journal of Biol. Medical Research; (2011). 2(4): 874– 877.
.William, F. E., Awoyemi, A. O., Parakoyi, D. B., Jolayemi, E. T. and Akande, T. M. Availability of antiretroviral and non-antiretroviral medicines in the management of HIV/AIDS patients in public hospitals in a North-Central State of Nigeria. West African Journal of Pharmacy; (2017). 28 (1): 129-140.
.Federal Ministry of Health (FMoH). Integrated National Guidelines for HIV Prevention,
Treatment and Care. Publication of the Federal Ministry of Health, Abuja, Nigeria (2016).
.Federal Ministry of Health (FMoH). Streamlined regimen for ART and PMTCT. Circular Letter Number C.3329/S.101/T1, dated 7th January 2014 of Federal Ministry of Health/National
AIDS/STDs Control Programme (2014).
.Federal Ministry of Health (FMoH). Integrated National Stock Status Report for Public Health Commodities (October December 2018). Publication of the Federal Ministry of Health, Abuja,Nigeria (2018).
.Federal Ministry of Health (FMoH). Integrated National Guidelines for HIV Prevention, Treatment and Care. Publication of the Federal Ministry of Health, Abuja, Nigeria (2014).
.Joseph, B. N., Wannang, N. N., Dangiwa, D. A. and Dapar, M. P. The economic, psychosocial burden and State ownership of HIV/AIDS Programme in Nasarawa State, Nigeria. West African Journal of Pharmacy; (2014). 25 (2): 125-136.